Phillyrin sensitizes lung cancer cells to ferroptosis through inhibiting FTH1/ SLC7A11 axis

被引:4
作者
Tang, Xu [1 ]
Teng, Jiajia [2 ]
Lu, Keyin [3 ]
机构
[1] Yueyang Peoples Hosp, Dept Intens Care Unit, Yueyang, Peoples R China
[2] Hunan Inst Sci & Technol, Dept Chem & Chem Engn, Yueyang, Peoples R China
[3] Yueyang Peoples Hosp, Dept Anesthesiol, West Baling Rd, Yueyang 414020, Hunan, Peoples R China
关键词
phillyrin; non-small cell; lung cancer; ferroptosis; FTH1; INFLAMMATION;
D O I
10.5414/CP204475
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ferroptosis is a newly found form of non-apoptotic regulated cell death that is essential for cancer progression. Phillyrin (PHN), an effective lignan glycoside of Forsythia suspensa, has been explored as a potential anticancer agent in some can-cer types. However, it is unclear whether and how PHN could promote the death of non-small cell lung cancer (NSCLC) cells by inducing ferroptosis. Our study showed for the first time that PHN induced cell death and attenuated cell proliferation in NSCLC cells in vitro and in vivo. Functional assays showed that ferroptosis was the predomi-nant form that contributed to PHN-induced cell death of NSCLC cells. Mechanistically, NSCLC cells exposed to PHN had a decreased ferritin heavy chain 1 (FTH1) and SLC7A11 protein expression. Exogenetic overexpres-sion of FTH1 substantially abrogated the tumor-inhibiting effects of PHN and further upregulated the expression of SLC7A11 in NSCLC cells. In conclusion, our findings sug-gest that the natural product PHN exerted its antitumor activity in NSCLC by promot-ing ferroptosis, and the FTH1/SLC7A11 axis plays an indispensable role in PHN-induced ferroptotic cell death.
引用
收藏
页码:8 / 19
页数:12
相关论文
共 29 条
[1]   Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis [J].
Chen, Guo-Qing ;
Benthani, Fahad A. ;
Wu, Jiao ;
Liang, Deguang ;
Bian, Zhao-Xiang ;
Jiang, Xuejun .
CELL DEATH AND DIFFERENTIATION, 2020, 27 (01) :242-254
[2]   Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11 [J].
Dong, Hui ;
Xia, Yangyang ;
Jin, Shanliang ;
Xue, Chaofan ;
Wang, Yanjun ;
Hu, Rong ;
Jiang, Hong .
CELL DEATH & DISEASE, 2021, 12 (11)
[3]  
Guo C, 2021, AM J CANCER RES, V11, P3039
[4]   Evaluating the safety of forsythin from Forsythia suspensa leaves by acute and sub-chronic oral administration in rodent models [J].
Han, Zhong ;
Lei, Xia-Ling ;
Zhang, Hong ;
Liu, Lu ;
Chen, Zhi-Sen ;
Yang, Wei ;
Lun, Zhao-Rong .
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2017, 10 (01) :47-51
[5]  
Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0111-2, 10.1038/s41572-019-0122-z]
[6]  
Herbert SL, BREAST CANCER-TOKYO
[7]   A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan [J].
Ishida, Kazushige ;
Ohnuki, Koji ;
Usami, Shin ;
Komatsu, Hideaki ;
Sasaki, Akira .
BREAST CANCER, 2021, 28 (01) :161-167
[8]   Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1 [J].
Kong, Na ;
Chen, Xiaying ;
Feng, Jiao ;
Duan, Ting ;
Liu, Shuiping ;
Sun, Xueni ;
Chen, Peng ;
Pan, Ting ;
Yan, Lili ;
Jin, Ting ;
Xiang, Yu ;
Gao, Quan ;
Wen, Chengyong ;
Ma, Weirui ;
Liu, Wencheng ;
Zhang, Mingming ;
Yang, Zuyi ;
Wang, Wengang ;
Zhang, Ruonan ;
Chen, Bi ;
Xie, Tian ;
Sui, Xinbing ;
Tao, Wei .
ACTA PHARMACEUTICA SINICA B, 2021, 11 (12) :4045-4054
[9]   Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy [J].
Koppula, Pranavi ;
Zhuang, Li ;
Gan, Boyi .
PROTEIN & CELL, 2021, 12 (08) :599-620
[10]   Pembrolizumab and atezolizumab in triple-negative breast cancer [J].
Kwapisz, Dorota .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) :607-617